252 related articles for article (PubMed ID: 10566766)
1. Elevated alpha-fetoprotein levels in hepatocellular carcinoma.
Yao FY
Am J Gastroenterol; 1999 Nov; 94(11):3387. PubMed ID: 10566766
[No Abstract] [Full Text] [Related]
2. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
3. Presence of a hepatoma-liver antigen in the sera of patients with primary hepatocellular carcinoma.
Oon CJ; Yo Sui Lan
Singapore Med J; 1979 Jun; 20(2):317-22. PubMed ID: 92056
[No Abstract] [Full Text] [Related]
4. [Primary liver cancer and hepatitis B infection in Senegal. Comparison of cancer patients with 2 control groups].
Michon J; Prince AM; Szmuness W; Demaille J; Diebolt G; Linhard J; Quenum C; Sankale M
Biomedicine; 1975 Sep; 23(7):263-266. PubMed ID: 60144
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Williams J; Livingston SE; Gretch D
J Viral Hepat; 2008 Mar; 15(3):179-87. PubMed ID: 18233991
[TBL] [Abstract][Full Text] [Related]
6. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Collazos J
Cancer; 1992 Sep; 70(5):1202-3. PubMed ID: 1381271
[No Abstract] [Full Text] [Related]
7. Serum -fetoprotein in hepatoma patients after liver transplantation.
Alpert E; Starzl TE; Schur PH; Isselbacher KJ
Gastroenterology; 1971 Aug; 61(2):144-8. PubMed ID: 4104962
[No Abstract] [Full Text] [Related]
8. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.
Chen DS; Sung FL
Gastroenterology; 1978 Jan; 74(1):163-4. PubMed ID: 72701
[No Abstract] [Full Text] [Related]
10. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
[TBL] [Abstract][Full Text] [Related]
11. Protocollagen proline hydroxylase in sera of Ugandans with hepatocellular carcinoma.
Keiser HR; Vogel CL; Sadikali F
J Natl Cancer Inst; 1972 Nov; 49(5):1251-5. PubMed ID: 4119495
[No Abstract] [Full Text] [Related]
12. [Serum gamma glutamyl transpeptidase in hepatobiliary diseases. Comparison with alkaline phosphatase and aryl amidase].
Schlaeger R; Schenzer R; Kattermann R
Med Klin; 1972 Apr; 67(15):521-6. PubMed ID: 4340792
[No Abstract] [Full Text] [Related]
13. Marked episodic elevations of alpha-fetoprotein without hepatocellular carcinoma in a patient with hepatitis B.
Wong CB; Attar BM; Shimoda SS
Am J Gastroenterol; 1995 Jun; 90(6):1015-6. PubMed ID: 7539578
[No Abstract] [Full Text] [Related]
14. [What can be the cause of elevated alpha-fetoprotein after hydrocele surgery?].
Reiner B
Dtsch Med Wochenschr; 2002 Mar; 127(9):465. PubMed ID: 11870565
[No Abstract] [Full Text] [Related]
15. Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma.
Lin CL; Chen JD; Liu CJ; Lee PH; Chen PJ; Lai MY; Kao JH; Chen DS
J Viral Hepat; 2007 Jan; 14(1):64-9. PubMed ID: 17212646
[TBL] [Abstract][Full Text] [Related]
16. Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study.
D'Antiga L; Aw M; Atkins M; Moorat A; Vergani D; Mieli-Vergani G
J Pediatr; 2006 Feb; 148(2):228-233. PubMed ID: 16492434
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B.
Shindo M; Hamada K; Nishioji K; Muramatsu A; Oda Y; Okuno T
J Gastroenterol; 2004; 39(3):260-7. PubMed ID: 15065004
[TBL] [Abstract][Full Text] [Related]
18. The natural history of chronic hepatitis B virus infection.
McMahon BJ
Semin Liver Dis; 2004; 24 Suppl 1():17-21. PubMed ID: 15192797
[TBL] [Abstract][Full Text] [Related]
19. The value of liver function tests in hepatocellular carcinoma.
Lopez JB; Balasegaram M; Thambyrajah V; Timor J
Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
[TBL] [Abstract][Full Text] [Related]
20. A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation.
Fontana RJ; Hann HW; Wright T; Everson G; Baker A; Schiff ER; Riely C; Anschuetz G; Riker-Hopkins M; Brown N;
Liver Transpl; 2001 Jun; 7(6):504-10. PubMed ID: 11443577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
